Stopping rules are predefined criteria in a clinical trial protocol that determine when a trial should be terminated early. These rules are established to protect participant safety, maintain data integrity, and ensure ethical conduct. Stopping rules may be based on interim analyses, safety concerns, efficacy findings, or futility assessments.